Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to severely active crohn?s disease | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to severely active crohn?s disease

Implementing Organization

All India Institute of Medical Sciences

Principal Investigator

Dr Vineet Ahuja

Professor

|

All India Institute of Medical Sciences

Abstract

NA

Patents

NA

Achievements

NA

Outcome / Output

NA

Publications

NA

Related Research

Funding Organization

Funding Organization

Gilead Sciences, Inc., USA

Quick Information

Area of Research

Life Sciences & Biotechnology

Focus Area

Gastroenterology

Start Year

2017

End Year

2021

Sanction Amount

₹ 10.00 L

Status

Completed

Contact

vins_ahuja@hotmail.com

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

NA

No. of Patents

Filed : 00

Grant : 00

Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.

Latest Updates

Loading…